Your browser doesn't support javascript.
loading
Genetic variation and evolutionary characteristics of Echovirus 11: new variant within genotype D5 associated with neonatal death found in China.
Ying, Liu; Qiang, Sun; Jinbo, Xiao; Binzhi, Ren; Hua, Zhao; Yong, Shi; Shuaifeng, Zhou; Mei, Hong; Kangping, Zhou; Jianping, Cun; Yunting, Zeng; Jianhua, Chen; Qiong, Ge; Yu, Ju; Huanhuan, Lu; Jichen, Li; Ruyi, Cong; Tingting, Yang; Rui, Wang; Yanjun, Zong; Tiantian, Sun; Liheng, Yu; Xiaoyi, Wang; Shuangli, Zhu; Dongmei, Yan; Tianjiao, Ji; Qian, Yang; Zhen, Zhu; Yong, Zhang.
Afiliación
  • Ying L; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Qiang S; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Jinbo X; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Binzhi R; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Hua Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Yong S; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Shuaifeng Z; Pathogen Detection Laboratory, Shanxi Provincial Center for Disease Control and Prevention, Shanxi, People's Republic of China.
  • Mei H; Pathogen Detection Laboratory, Chongqing Provincial Center for Disease Control and Prevention, Chongqing, People's Republic of China.
  • Kangping Z; Pathogen Detection Laboratory, Jiangxi Provincial Center for Disease Control and Prevention, Jiangxi, People's Republic of China.
  • Jianping C; Pathogen Detection Laboratory, Hunan Provincial Center for Disease Control and Prevention, Hunan, People's Republic of China.
  • Yunting Z; Pathogen Detection Laboratory, Xizang Provincial Center for Disease Control and Prevention, Xizang, People's Republic of China.
  • Jianhua C; Pathogen Detection Laboratory, Hubei Provincial Center for Disease Control and Prevention, Hubei, People's Republic of China.
  • Qiong G; Pathogen Detection Laboratory, Yunnan Provincial Center for Disease Control and Prevention, Yunnan, People's Republic of China.
  • Yu J; Pathogen Detection Laboratory, Hainan Provincial Center for Disease Control and Prevention, Hainan, People's Republic of China.
  • Huanhuan L; Pathogen Detection Laboratory, Gansu Provincial Center for Disease Control and Prevention, Gansu, People's Republic of China.
  • Jichen L; Pathogen Detection Laboratory, Zhejiang Provincial Center for Disease Control and Prevention, Zhejiang, People's Republic of China.
  • Ruyi C; Pathogen Detection Laboratory, Guangxi Provincial Center for Disease Control and Prevention, Guangxi, People's Republic of China.
  • Tingting Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Rui W; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Yanjun Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Tiantian S; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Liheng Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Xiaoyi W; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Shuangli Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Dongmei Y; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Tianjiao J; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Qian Y; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
  • Zhen Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
  • Yong Z; WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Rep
Emerg Microbes Infect ; 13(1): 2361814, 2024 Dec.
Article en En | MEDLINE | ID: mdl-38828746
ABSTRACT
Echovirus 11 (E11) has gained attention owing to its association with severe neonatal infections. From 2018 to 2023, a surge in severe neonatal cases and fatalities linked to a novel variant of genotype D5 was documented in China, France, and Italy. However, the prevention and control of E11 variants have been hampered by limited background data on the virus circulation and genetic variance. Therefore, the present study investigated the circulating dynamics of E11 and the genetic variation and molecular evolution of genotype D5 through the collection of strains from the national acute flaccid paralysis (AFP) and hand, foot, and mouth disease (HFMD) surveillance system in China during 2000-2022 and genetic sequences published in the GenBank database. The results of this study revealed a prevalent dynamic of E11 circulation, with D5 being the predominant genotype worldwide. Further phylogenetic analysis of genotype D5 indicated that it could be subdivided into three important geographic clusters (D5-CHN1 2014-2019, D5-CHN2 2016-2022, and D5-EUR 2022-2023). Additionally, variant-specific (144) amino acid mutation sites and positive-selection pressure sites (132, 262) were identified in the VP1 region. Cluster-specific recombination patterns were also identified, with CVB5, E6, and CVB4 as the major recombinant viruses. These findings provide a preliminary landscape of E11 circulation worldwide and basic scientific data for further study of the pathogenicity of E11 variants.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Filogenia / Variación Genética / Enterovirus Humano B / Evolución Molecular / Genotipo País/Región como asunto: Asia Idioma: En Revista: Emerg Microbes Infect Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Filogenia / Variación Genética / Enterovirus Humano B / Evolución Molecular / Genotipo País/Región como asunto: Asia Idioma: En Revista: Emerg Microbes Infect Año: 2024 Tipo del documento: Article